NACL, a Leading Agrochemical Company, Achieves 100% Transparency Across 4 Plants and Reduces Freight Costs by 3-4%
Case Study NACL, a Leading Agrochemical Company, Achieves 100% Transparency Across 4 Plants and Reduces
Case Study NACL, a Leading Agrochemical Company, Achieves 100% Transparency Across 4 Plants and Reduces
Despite the growing recognition of digital tools’ potential in logistics, a significant 87.5% of organizations fail to meet
As we enter 2021, the whole thing seems to be revolving around the Covid-19 vaccine and its availability. As various governments give the nod to vaccines, one of the critical questions which needs to be answered is how the vaccine will reach billions of people. The vaccine makers are working 24/7 to come out with the best solutions and make sure that the vaccine would stand well against the new mutated version of the virus. Out of four vaccines that are showing great results, three exceed 90% efficacy which is showing a sign of success in the fight against this pandemic. However, the challenge of eradicating this pandemic isn’t limited to developing a vaccine but also distributing it to the masses.
According to the WHO ACT- Accelerator Framework, countries will first get 3% doses, then 20% of the population, and in the end, full vaccination. This Accelerator is not a decision-making body but a collaboration platform to bring together governments, scientists, and civil society for equitable access to COVID-19 vaccines and treatments. Key challenges which are going to come as we cover the entire global population: are supply chain management, logistics and transportation, storage and inventory management, maintaining adequate production, and, most importantly, who gets vaccinated first. Countries need to identify vulnerable populations to distribute the vaccine. Most of the vaccines require at least two doses which again complicates the distribution and manufacturing.
National immunization program has the scope to improve their performance to provide the right vaccine at the right cost, in the right condition at the right time. Effective Vaccine Management (EVM) includes the following:
Vaccine arrival procedures make sure that the shipment of vaccine from a manufacturer reaches its destination in a country with no damaged vaccines in it.
With WHO-recommended temperature range for the type of vaccine diluents and vaccine distributed and stored within a cold-chain system.
Storage capacity: Supply chain system must have transport storage capacity and quality cold storage with sufficient dry storage.
Cold-chain equipment, storage buildings, and vehicles with status make the supply chain function effectively.
Storage buildings, cold-chain equipment, and vehicles require standard and operational maintenance systems.
Technologies and systems for good warehousing practice, physical inventory, disposal of damaged vaccines, and adequate stock-level policy.
High effectiveness is required for the transport of vaccines between each level in the supply chain, with best packing practices with coolant packs and temperature indicators.
The use of diluents, monitoring of vaccine wastage, and use of vaccine vial monitors are adopted and implemented according to the recommended policies for vaccine management.
Logistics Management Information Systems (LMIS) is effective, including vaccine-needs forecasting and standard operating procedures.
According to WHO, less than 25% of countries are meeting criteria of stock management, maintenance, and distribution. Almost 29% of countries meet the criteria of minimum standards for temperature control. WHO recommends that national immunization programs must analyze their supply chains for related supplies, to reduce avoidable wastage and to improve the distribution of the covid-19 vaccine.
The global scientific community is working at a breakneck pace on the development of vaccines, but their distribution will pose tremendous logistical challenges for governments. There is a good degree of risk involved in the transportation of vaccines, which cannot be ignored. The global vaccine demand is to produce the vaccine for 7.8 billion people. Air Cargo capacity in 2021 will be in high demand to deliver the vaccines to various parts of the world. Key challenges with the distribution of the covid-19 are as follows: –
Temperature needed for storage of the COVID-19 vaccine is between -60 degree Celsius to -90 degree Celsius, which also requires specialized transport and storage channels to manage the vaccine temperature. UNICEF is going to have 65,000 solar cold-chain fridges in less developed countries. Vaccines will require large cold storage facilities with manpower having adequate handling expertise.
Because high demand with limited supplies in the initial days will make it an easy target for theft. Logistics of vaccines requires secured loading and special planning to avoid pilferage and robbery. Panic can create a situation of tampering and robbery in the supply chain. Secured loading and Safeguarding of vaccines is required, like that of valuable goods like currency notes, gold, and defense equipment.
Governments will make decisions about which groups should be vaccinated first. Equitable distribution will require the identification of vulnerable populations in a transparent manner. Most of the national vaccine programs are designed for children’s immunization, not for adult vaccination.
Vaccine manufacturers require optimal distribution systems in a complex web of stakeholders – manufacturers, public health officers, distributors, pharmacists, and others for efficient delivery of vaccines. It will help in forecasting the demand and will improve the just-in-time delivery of vaccines. Manufacturers have to collaborate with stakeholders to exchange data like potential delays in real-time, expected delivery dates, and the number of vials shipped to ultimately model the supply chain. Most of the vaccines require at least two doses which increases complexities in logistics and supply.
It is important to know how to efficiently forecast supply and demand and store and deliver vaccines with the help of tools and processes for regular and reliable data. It’s a continuous quality improvement process compared with best-practice benchmarks. In major national immunization programs, data may be lost, geographically dispersed, or not recorded on paper or systems. To prioritize areas where attention and improvement are required, use supply chain management solutions that can analyze immunization supply chain systems from distributed data and store them in information systems.
After measuring the immunization supply chain system and how it handles supply, demand, storage, and delivery and how it represents key metrics and provides actionable insights to the key stakeholders. By taking advantage of gathered data, large-scale changes can be made supported by proven and novel approaches. Supply chain redesign is the logistical analysis for the reconfiguration of processes, such as increasing the frequency of shipments or changing warehouse locations. Logistics Management Information Systems (LMIS) help in improving the information such as received, administered, or wasted, stock-on-hand.
Immunization programs need funding, people, and data to prevent disease. Investment is required to train, incentivize and reward data managers, managers, warehouse workers, and logisticians are the backbones of the Immunization supply chain system.
An effective logistics system is going to be the backbone of this immunization drive. Effective cold chain logistics service providers, real-time tracking, and dispatch planning will hold the key to the effective distribution of the vaccine. Real-time visibility and rapid exceptional handling capabilities would be needed to manage the delivery of vaccines from the origin of manufacturing to the final delivery point. An effective supply chain management system must have the capability to manage these elements – the right quantity, right product, right time, right condition, right place, right service provider, and right cost.
India has better access to vaccines compared to other developing countries, but the distribution of the vaccine with existing cold chain capacity seems to be a daunting task. Serum Institute of India will be producing 1 billion doses of the vaccine by 2021. Currently, India has a 28,000-unit cold storage point, 76,000 cold chain equipment, 55,000 cold chain handlers, 2.5 million health workers, and 700 reefer vans which are used for national immunization programs, but there is no company that can manage the supply chain of vaccines that require -25 degrees Celsius according to The Indian Express. If it is going to be a two-dose vaccine, India will require a large health workforce to administer more than 2 billion doses. The Indian government is working to identify cold chain storage facilities that have the capacity for storing vaccines. Food cold-chain storage (FCI) can be utilized for the last-mile availability of the vaccine.
The Indian government is aiming to vaccinate the most vulnerable 300 million people with 600 million doses by August 2021, which seems a hard target to achieve with the current cold storage infrastructure.
How will the entire global population be vaccinated remains an interesting question. And one can say confidently that in this age of cutting-edge technology, an effective digitized Supply Chain Strategy would be needed to manage the global distribution of the COVID-19 vaccine.
To learn more about how SuperProcure can help your logistics team reach the next level with relevant technology, please reach us to share your details, and we will be happy to get in touch with you.
Sources: Business-standard, Live-Mint
Subscribe to our blog for the latest news and updates
Ensure your company’s data is completely secure and compliant with the latest regulatory standards
5/5
4.5/5
5/5
4.5/5
Solutions
Industry
Real Time Freight Sourcing And Collaboration Platform
Unit 3B, 4 Bakul Bagan Row, Lansdowne Market. Kolkata- 700025, India
Share us the details to connect to a relevant team member.